We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 125

Court of Appeal upholds decision relating to sildenafil use patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13 Drug: VIAGRA sildenafil In Apotex' action for impeachment of the Pfizer patent

Antibody patent found valid and infringed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

The Court recently decided a patent infringement case dealing with antibodies. The claims at issue in AbbVie’s patent relate to the use of a human

Allegations as to non-infringement of Form I held to be justified

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2014

Teva asserted both non-infringement and invalidity in its Notice of Allegation. The Court noted that invalidity of this patent had been before it

Judicial review brought outside time period and no vested right to NOC

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This decision relates to the consideration by the Minister of Health of Apotex’ submission for a Notice of Compliance (NOC) for omeprazole magnesium

Definition of “innovative drug” does not include variations

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s

Pfizer Canada Inc. v. Novopharm, The Minister of Health, Northwestern University and the Board of Regents for the University of Oklahoma

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

In a proceeding pursuant to the Patented Medicines (Notice of Compliance) Regulations, Novopharm brought a motion seeking a Protective Order that allowed the designation of Novopharm's Notice of Allegation (NOA) as confidential

Sandoz Canada v. Abbott

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is an appeal and cross-appeal from a decision of the Federal Court in a proceeding commenced pursuant to the Patented Medicines (Notice of Compliance) Regulations

Purdue Pharma v. Canada (Minister of Health)

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 26 2010

The Court dismissed an application for judicial review of the Minister of Health's decision refusing to list a patent on the Patent Register

Eli Lilly Canada v. Novopharm Limited

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 4 2010

The Court of Appeal overturned the decision of the trial judge which held that the patent was invalid

Pfizer v. Ratiopharm

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 11 2010

The Court of Appeal dismissed Pfizer's appeal from a Trial Judge decision finding the patent at issue to be invalid